79 results in Exploration of Digestive Diseases
Most Viewed
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Drug-induced cholestasis: causative agents and challenges in diagnosis and management
Jose M. Pinazo-Bandera ... Miren García-Cortés
Published: September 18, 2023 Explor Dig Dis. 2023;2:202–222
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Etiopathogenesis and pathophysiology of cholestasis
Maitane Asensio ... Jose J. G. Marin
Published: October 31, 2022 Explor Dig Dis. 2022;1:97–117
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Fructose, a trigger of metabolic diseases?—a narrative review
Anja Baumann ... Ina Bergheim
Published: August 29, 2022 Explor Dig Dis. 2022;1:51–71
Open Access
Review
Hepatitis B virus: modes of transmission, immune pathogenesis, and research progress on therapeutic vaccines
Chunzheng Li ... Xianguang Yang
Published: October 14, 2024 Explor Dig Dis. 2024;3:443–458
This article belongs to the special issue Viral Hepatitis
Open Access
Review
Alcohol-related liver disease: also a question of what you drink?
Finn Jung ... Ina Bergheim
Published: June 30, 2023 Explor Dig Dis. 2023;2:118–132
Open Access
Review
Helicobacter pylori and gastric cancer: a critical approach to who really needs eradication
Elias Kouroumalis ... Argyro Voumvouraki
Published: April 16, 2024 Explor Dig Dis. 2024;3:107–142
This article belongs to the special issue Helicobacter Pylori and Infection: Genomics, Diagnosis, Pathogenesis, Antibiotic Resistance, Microbiota, Cancer, Prevention and Therapeutics
Open Access
Review
Zebrafish as a model for drug induced liver injury: state of the art and beyond
Gulcin Cakan-Akdogan ... Ozlen Konu
Published: April 26, 2023 Explor Dig Dis. 2023;2:44–55
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Review
The central role of mitochondrial metabolism in hepatic steatosis
Sanda Win ... Filbert Win Min Aung
Published: February 29, 2024 Explor Dig Dis. 2024;3:42–68
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Tumor immune microenvironment modulation by cholesterol in hepatocellular carcinoma
Alejandro Escobedo-Calvario ... María Concepción Gutiérrez-Ruíz
Published: July 29, 2022 Explor Dig Dis. 2022;1:21–39
Open Access
Review
Role of oxidative stress and endoplasmic reticulum stress in drug-induced liver injury
Hanghang Wu ... Francisco Javier Cubero
Published: June 28, 2023 Explor Dig Dis. 2023;2:83–99
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Review
Extracellular vesicles in metabolic dysfunction associated fatty liver disease: mechanisms, diagnostic and therapeutic implications
Zongmei Wu ... Han Moshage
Published: July 13, 2022 Explor Dig Dis. 2022;1:4–20
Open Access
Review
Hepatocellular carcinoma surveillance after HBsAg seroclearance
Jimmy Che-To Lai ... Terry Cheuk-Fung Yip
Published: May 11, 2024 Explor Dig Dis. 2024;3:175–189
This article belongs to the special issue Chronic Hepatitis B and C
Open Access
Review
Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Chunye Zhang ... Ming Yang
Published: October 25, 2023 Explor Dig Dis. 2023;2:246–275
This article belongs to the special issue Cellular and Molecular Targets for NAFLD or MAFLD Treatments and Their Functions in Liver Fibrosis, Cirrhosis, and Cancer
Open Access
Review
Pathophysiology of biochemical signs of primary biliary cholangitis
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev
Published: August 27, 2023 Explor Dig Dis. 2023;2:149–171
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases
Hala Saeed Jaara, Sandra Torres
Published: December 10, 2024 Explor Dig Dis. 2024;3:474–503
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Perspective
Transabdominal Gastro-Intestinal UltraSound (GIUS): a visual approach to intestinal pathology
Cristina Felicani ... Pietro Andreone
Published: July 05, 2024 Explor Dig Dis. 2024;3:241–261
This article belongs to the special issue Advances in Hepato-gastroenterology: Diagnosis, Prognostication, and Disease Stratification
Open Access
Review
Ascites in cirrhotic patients: a comprehensive review
Paul Carrier ... Laure Elkrief
Published: August 26, 2024 Explor Dig Dis. 2024;3:362–381
This article belongs to the special issue Cirrhosis and Its Complications
Open Access
Review
Lysosomal hydrolases, from waste-bags effectors to essential multipurpose enzymes in liver fibrosis
María Fernández-Fernández ... Anna Moles
Published: February 22, 2023 Explor Dig Dis. 2023;2:1–10
Open Access
Original Article
The hepatocyte growth factor induces an anti-inflammatory and repairing response in the cholestasis-induced colon damage
Jocelyn López-Ramirez ... Leticia Bucio-Ortiz
Published: August 11, 2022 Explor Dig Dis. 2022;1:40–50
Open Access
Review
Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review
Miren García-Cortés ... Alberto García-García
Published: December 27, 2023 Explor Dig Dis 2023;2:318–336
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Journal Information